2546117-79-5

Resencatinib is a tyrosine kinase inhibitor with potential as an antineoplastic agent.

Resencatinib is a potent tyrosine kinase inhibitor with antineoplastic activity[1]. Resencatinib is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

[1] WHO Drug Information-World Health Organization (WHO).